NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
Back to search
Official data from USPTO
INSILICO MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INSILICO MEDICINE
ST13
US500000097552528Class
5
Filing
97552528
Registration
7377270
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/07/2024
Trademark type
Word
Nice classes
5
Filing date
08/17/2022
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
05/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Central, HK
Examiner
SPILS, CAROL
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Insilico Medicine IP Limited
Representatives
Gregory J. Chinlund Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of fibrosisoncologyimmunologyanti-infectiouscentral nervous system related and other diseases and disorders; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposesfor treating fibrosisoncologyimmunologyanti-infectiouscentral nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form of capsules; Pharmaceutical and biological preparations for the treatment of fibrosisoncologyimmunologyanti-infectiouscentral nervous system related and other diseases and disorders and cancer for medical purposes
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/31/2024
OTHE
CASE RETURNED TO EXAMINATION
01/12/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/12/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/08/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
12/08/2023
APET
ASSIGNED TO PETITION STAFF
12/07/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
11/13/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/09/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2023
PUBO
PUBLISHED FOR OPPOSITION
09/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/26/2023
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
06/13/2023
ALIE
ASSIGNED TO LIE
06/13/2023
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
06/07/2023
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
06/07/2023
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
06/07/2023
DOCK
ASSIGNED TO EXAMINER
05/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2022
NWAP
NEW APPLICATION ENTERED
08/20/2022
Continuous trademark protection
Get notified about every new filing that threatens INSILICO MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.